เอกสารอ้างอิง
[1]. Kaunitz AM. Abnormal uterine bleeding in nonpregnant reproductive-age patients: Evaluation and approach to diagnosis In: Post TW, ed. UptoDate, Waltham: UptoDate; 2021. (Accessed on May 23, 2021.) Available at: https://www.uptodate.com/contents/abnormal-uterine-bleeding-in-nonpregnant-reproductive-age-patients-evaluation-and-approach-to-diagnosis?search=1.%09UptoDate:%20Abnormal%20uterine%20bleeding%20in%20nonpregnant%20reproductive-age%20patients&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H1.
[2]. American College of Obstetricians and Gynecologists. Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women [Internet]. [cited 2021 May 23]. Available from:https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2013/04/ management-of-acute-abnormal-uterine-bleeding-in-nonpregnant-reproductive-aged-women.
[3]. ราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย. การหาสาเหตุและรักษาภาวะเลือดออกผิดปกติจากโพรงมดลูก ในวัยรุ่นและวัยเจริญพันธุ์ [อินเตอร์เน็ต]. 2563 [เข้าถึงเมื่อ 23 พฤษภาคม 2564]. เข้าถึงได้จาก http://www.rtcog.or.th/home/gy-07%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%AB%E0%
B8%B2%E0%B8%AA%E0%B8%B2%E0%B9%80%E0%B8%AB%E0%B8%95%E0%B8%B8%E0%B9%81%E0%B8%A5%E0%B8%B0%E0%B8%A3%E0%B8%B1%E0%B8%
81%E0%B8%A9%E0%B8%B2%E0%B8%A0%E0%B8%B2/765/.
[4].Roxithromycin. In DRUGDEX® System [database on the internet]. Greenwood Village, Co: Thomson Micromedex. [cited 2021 May 23]. Available from: https://www.micromedexsolutions .com/micromedex2/librarian/PFDefaultActionId/evidencexpert.DoIntegratedSearch?navitem=topHome&isToolPage=true#.
[5]. Poirier R. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy. 1991;27(suppl A):109–16. doi: 10.1093/jac/27.suppl_a.109.
[6]. Muller O. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. Journal of Antimicrobial Chemotherapy. 1996;37(suppl C):83–92. doi: 10.1093/jac/37.suppl_c.83.
[7]. Paulsen O, Christensson BA, Hebelka M, Ljungberg B, Nilsson-ehle I, Nyman L, et al. Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lower respiratory tract infections. Scandinavian Journal of Infectious Diseases. 1992;24(2):219–25. doi: 10.3109/00365549209052616.
[8]. Ogrendik M. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 2009;31(8):1754–64. doi: 10.1016/j.clinthera.2009.08.014.
[9]. Pechère J-C. Clinical evaluation of roxithromycin 300 mg once daily as an alternative to 150 mg twice daily. Diagnostic Microbiology and Infectious Disease. 1992;15(4):111–7. doi: 10.1016/0732-8893(92)90137-i.